Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.480
-0.060 (-3.90%)
Mar 28, 2025, 4:00 PM EDT - Market closed

Metagenomi Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-78.06-68.26-43.59-21.44
Depreciation & Amortization
5.414.211.730.39
Asset Writedown & Restructuring Costs
1.040.020.28-
Loss (Gain) From Sale of Investments
3.02-11.34-1.22-2.56
Stock-Based Compensation
16.26.921.960.38
Other Operating Activities
2.983.471.081.24
Change in Accounts Receivable
1.19-1.18-1.27-
Change in Accounts Payable
-1.11-0.080.720.7
Change in Unearned Revenue
-46.8-30.365.6644.23
Change in Income Taxes
-3.271.731.54-
Change in Other Net Operating Assets
-9.693.42.841.33
Operating Cash Flow
-109.07-91.4129.7224.26
Operating Cash Flow Growth
--22.54%-
Capital Expenditures
-3.11-9.81-13.98-2.9
Investment in Securities
-85.0455.55-108.22-71.41
Investing Cash Flow
-88.1645.73-122.2-74.32
Long-Term Debt Issued
---29.97
Net Debt Issued (Repaid)
---29.97
Issuance of Common Stock
84.01---
Other Financing Activities
--3.28--
Financing Cash Flow
84.011.01239.5939.92
Net Cash Flow
-113.22-44.66147.12-10.14
Free Cash Flow
-112.19-101.2215.7521.35
Free Cash Flow Growth
---26.26%-
Free Cash Flow Margin
-214.53%-226.17%91.55%8787.65%
Free Cash Flow Per Share
-3.40-29.734.633.75
Cash Interest Paid
--2.161.45
Cash Income Tax Paid
3.512.25--
Levered Free Cash Flow
-73.35-31.65-19.71-
Unlevered Free Cash Flow
-73.35-31.65-19.65-
Change in Net Working Capital
36.28-16.09-18.53-
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q